Frequent HLA class I loss is an early event in cervical carcinogenesis

Human Immunology

Volumn 66, Issue 11, 2005, Pages 1167-1173

  Vermeulen, Christine F W ^a,b   Jordanova, Ekaterina S ^a   Zomerdijk Nooijen, Yvon A ^a   Ter Haar, Natalja T ^a   Peters, Alexander A W ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b L1 Q ^*  (Netherlands)

Author keywords

Adjacent CIN lesion; Cervical cancer; HLA class I; LOH; Loss of expression

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE MARKER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOMES, HUMAN, PAIR 6; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 33645233793     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2005.10.011     Document Type: Article

References (40)

1. D.M. Parkin, P. Pisani, J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 806 1999 827
2. P. Pisani, D.M. Parkin, F. Bray, J. Ferlay Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 831 1999 18
3. A.P. Vizcaino, V. Moreno, F.X. Bosch, N. Munoz, X.M. Barros-Dios, J. Borras, D.M. Parkin International trends in incidence of cervical cancer: II. Squamous-cell carcinoma Int J Cancer 863 2000 429
4. J.M. Walboomers, C.J. Meijer Do HPV-negative cervical carcinomas exist? [Editorial] J Pathol 1813 1997 253
5. C.S. Herrington Do HPV-negative cervical carcinomas exist? - Revisited J Pathol 1891 1999 1
6. J.M.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J.F. Snijders, J. Peto, C.J.L.M. Meijer, N. Munoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 1891 1999 12
7. N. Munoz Human papillomavirus and cancer the epidemiological evidence J Clin Virol 191 2000 1
8. C.M. D'Urso, Z.G. Wang, Y. Cao, R. Tatake, R.A. Zeff, S. Ferrone Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression J Clin Invest 871 1991 284
9. F. Garrido, F. Ruiz-Cabello, T. Cabrera, J.J. Pérez-Villar, M. López-Botet, M. Duggan-Keen, P.L. Stern Implications for immunosurveillance of altered HLA class I phenotypes in human tumours Immunol Today 18 1997 89
10. S.A. Riemersma, E.S. Jordanova, R.F.J. Schop, K. Philippo, L.H.J. Looijenga, E. Schuuring, P.M. Kluin Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites Blood 9610 2000 3569
11. L.A. Koopman, W.E. Corver, A.R. Van der Slik, M.J. Giphart, G.J. Fleuren Multiple genetic alterations cause frequent and heterogeneous HLA class I antigen loss in cervical cancer J Exp Medi 1916 2000 961
12. A.B. Mitra, V.V.V.S. Murty, R.G. Li, M. Pratap, U.K. Luthra, R.S.K. Chaganti Allelotype analysis of cervical carcinoma Cancer Res 54 1994 4481
13. F. Kisseljov, L. Semionova, E. Samoylova, N. Mazurenko, E. Komissarova, V. Zourbitskaya, T. Gritzko, V. Kozachenko, M. Netchushkin, S. Petrov, A. Smirnov, A. Alonso Instability of chromosome 6 microsatellite repeats in human cervical tumors carrying papillomavirus sequences Int J Cancer (Pred Oncol) 69 1996 484
14. J.S. Rader, T. Kamarasova, P.C. Huettner, L. Li, Y. Li, D.S. Gerhard Allelotyping of all chromosomal arms in invasive cervical cancer Oncogene 13 1996 2737
15. M.R. Mullokandov, N.G. Kholodilov, N.B. Atkin, R.D. Burk, A.B. Johnson, H.P. Klinger Genomic alterations in cervical carcinoma losses of chromosome heterozygosity and human papilloma virus tumor status Cancer Res 56 1996 197
16. E.J. Krul, A.M. Kersemaekers, Y.A. Zomerdijk-Nooyen, C.J. Cornelisse, L.A. Peters, G.J. Fleuren Different profiles of allelic losses in cervical carcinoma cases in Surinam and The Netherlands Cancer 866 1999 997
17. P. Holowaty, A.B. Miller, T. Rohan, T. To Natural history of dysplasia of the uterine cervix-response J Natl Cancer Inst 9116 1999 1420
18. K. Nasiell, V. Roger, M. Nasiell Behavior of mild cervical dysplasia during long-term follow-up Obstet Gynecol 675 1986 665
19. A.G. Ostor Natural history of cervical intraepithelial neoplasia-a critical review Int J Gynecol Pathol 122 1993 186
20. A. Chatterjee, H.A. Pulido, S. Koul, N. Beleno, A. Perilla, H. Posso, M. Manusukhani, V.V.V.S. Murty Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions Cancer Res 615 2001 2119
21. H. Arias-Pulido, N. Joste, C.M. Wheeler Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRBI* (*)1501-DQB1* (*)0602 haplotype Genes Chromosomes Cancer 404 2004 277
22. A.M.F. Kersemaekers, G.G. Kenter, J. Hermans, G.J. Fleuren, M.J. van de Vijver Allelic loss and prognosis in carcinoma of the uterine cervix Int J Cancer (Pred Oncol) 79 4 1998 411 417
23. N.J. Stam, H. Spits, H.L. Ploegh Monoclonal antibodies raised against denatured HLA-b locus heavy-chains permit biochemical-characterization of certain HLA-c locus products J Immunol 1377 1986 2299
24. M.F. Sernee, H.L. Ploegh, D.J. Schust Why certain antibodies cross-react with HLA-A and HLA-G epitope mapping of two common MHC class I reagents Mol Immunol 353 1998 177
25. F. Perosa, G. Luccarelli, M. Prete, E. Favoino, S. Ferrone, F. Dammacco Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide J Immunol 1714 2003 1918
26. N.L.G. Sieben, S.M. Kolkman-Uljee, A.M. Flanagan, S. le Cessie, A.M. Cleton-Jansen, C.J. Cornelisse, G.J. Fleuren Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors AJP 1624 2003 1095
27. A. Foissac, A. Cambon-Thomsen Microsatellites in the HLA region 1998 update Tissue Antigens 524 1998 318
28. A. Foissac, M. Salhi, A. Cambon-Thomsen Microsatellites in the HLA region 1999 update Tissue Antigens 556 2000 477
29. M.A. Hoeve, S.C.F. Mota, E. Schuuring, W.J.F. de Leeuw, A. Chott, J.P.P. Meijerink, P.M. Kluin, J.H.J.M. van Krieken Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphoma Leukemia 1311 1999 1804
30. N.L.G. Sieben, N.T. Ter Haar, C.J. Cornelisse, G.J. Fleuren, A.M. Cleton-Jansen PCR artifacts in LOH and MSI analysis of microdissected tumor cells Human Pathol 3111 2000 1414
31. P. Devilee, A.M. Cleton-Jansen, C.J. Cornelisse Ever since Knudson Trends Genet 1710 2001 569
32. E.S. Jordanova, S.A. Riemersma, K. Philippo, M. Giphart-Gassler, E. Schuuring, P.M. Kluin Hemizygous deletions in the HLA region account for loss of heterozygosity in the majority of diffuse large B-cell lymphomas of the testis and the central nervous system Genes Chromosomes Cancer 351 2002 38
33. J.W. Vaandrager, E. Schuuring, T. Raap, K. Philippo, K. Kleiverda, P. Kluin Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes Genes Chromosomes Cancer 271 2000 85
34. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, S.J. Meltzer, M.A. Rodriguez-Bigas, R. Fodde, G.N. Ranzani, S. Srivastava A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 5822 1998 5248
35. R.J.C. Slebos, D.S. Oh, D.M. Umbach, J.A. Taylor Mutations in tetranucleotide repeats following DNA damage depend on repeat sequence and carcinogenic agent Cancer Res 6221 2002 6052
36. G. Singer, T. Kallinowski, A. Hartmann, W. Dietmaier, P.J. Wild, P. Schraml, G. Sauter, M.J. Mihatsch, H. Moch Different types of microsatellite instability in ovarian carcinoma Int J Cancer 1124 2004 643
37. N.S. Dangoria, M.L. Delay, D.J. Kingsbury, J.P. Mear, B. Uchanska-Ziegler, A. Ziegler, R.A. Colbert HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum J Biol Chem 27726 2002 23459
38. H.J. Bontkes, J.M. Walboomers, C.J. Meijer, T.J. Helmerhorst, P.L. Stern Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression [Letter] Lancet 351 9097 1998 187
39. L.M. Torres, T. Cabrera, A. Concha, M.R. Oliva, F. Ruiz-Cabello, F. Garrido HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix Tissue Antigens 412 1993 65
40. S.S. Glew, M.E. Connor, P.J.F. Snijders, C.M. Stanbridge, C.H. Buckley, J.M.M. Walboomers, C.J.L.M. Meijer, P.L. Stern HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection Eur J Cancer 14 1993 1963